ArticleThe Journal of infection2021
SARS-CoV-2 RNAemia is associated with severe chronic underlying diseases but not with nasopharyngeal viral load.
Abstract readLetterComment
In one paragraph
Article in The Journal of infection, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 2 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 2 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
14 citing papers in PubMed, 2 syntheses or guidelines pooled it.
- The relationship between COVID-19 viral load and disease severity: A systematic review.Immunity, inflammation and disease · 2022Pooled it
- Quantitative assessment of SARS-CoV-2 RNAemia and outcome in patients with coronavirus disease 2019.Journal of medical virology · 2021Pooled it
- Droplet Digital PCR or Real-Time PCR as a Method for Quantifying SARS-CoV-2 RNA in Plasma-Is There a Difference?Viruses · 2025Article
- Article
- Diagnostic value and characteristic analysis of serum nucleocapsid antigen in COVID-19 patients.PeerJ · 2023Article
- Relevant SARS-CoV-2 viremia is associated with COVID-19 severity: Prospective cohort study and validation cohort.Journal of medical virology · 2022Observational
- Plasma SARS-CoV-2 nucleocapsid antigen levels are associated with progression to severe disease in hospitalized COVID-19.Critical care (London, England) · 2022Observational
- Correlation of SARS-CoV-2 Nasopharyngeal CT Values With Viremia and Mortality in Adults Hospitalized With COVID-19.Open forum infectious diseases · 2022Article
- Therapeutic implications of ongoing alveolar viral replication in COVID-19.The Lancet. Rheumatology · 2022Review
- SARS-CoV-2 loads in urine, sera and stool specimens in association with clinical features of COVID-19 patients.Journal of clinical virology plus · 2022Article
- SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.Journal of medical virology · 2022Article
- SARS-CoV-2 viremia is associated with distinct proteomic pathways and predicts COVID-19 outcomes.The Journal of clinical investigation · 2021Article
- Pathophysiology of infection with SARS-CoV-2-What is known and what remains a mystery.Respirology (Carlton, Vic.) · 2021Review
- A tricompartmental model of lung oxygenation disruption to explain pulmonary and systemic pathology in severe COVID-19.The Lancet. Respiratory medicine · 2021Review
Corrections and comments
- Comment on
Authors and funding
24 authors.
Judith Berastegui-CabreraUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain.
Sonsoles Salto-AlejandreUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain.
Maricela ValerioService of Clinical Microbiology and Infectious Diseases, Sanitary Research Institute, Gregorio Marañón University Hospital, Madrid, Spain.
Patricia Pérez-PalaciosUnit of Infectious Diseases, Microbiology, and Preventive Medicine. Virgen Macarena University Hospital, Seville, Spain.
Francisco Arnaiz-De Las RevillasService of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain.
Gabriela Abelenda-AlonsoService of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
José Antonio Oteo-RevueltaDepartment of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain.
Marta Carretero-LedesmaUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain.
Patricia MuñozService of Clinical Microbiology and Infectious Diseases, Sanitary Research Institute, Gregorio Marañón University Hospital, Madrid, Spain; CIBERES (CB06/06/0058), Department of Medicine, Faculty of Medicine, Complutense University, Madrid, Spain.
Álvaro PascualInstitute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain; Unit of Infectious Diseases, Microbiology, and Preventive Medicine. Virgen Macarena University Hospital, Seville, Spain.
Mónica GozaloService of Microbiology, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, Santander, Spain.
Alexander RombautsService of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Jorge AlbaDepartment of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain.
Emilio García-DíazUnit of Emergencies, Virgen del Rocío University Hospital, Seville, Spain.
María Luisa Rodríguez-FerreroService of Clinical Microbiology and Infectious Diseases, Sanitary Research Institute, Gregorio Marañón University Hospital, Madrid, Spain.
Adoración ValienteUnit of Infectious Diseases, Microbiology, and Preventive Medicine. Virgen Macarena University Hospital, Seville, Spain.
María Carmen FariñasService of Infectious Diseases, Marqués de Valdecilla University Hospital, Marqués de Valdecilla-IDIVAL, University of Cantabria, Santander, Spain.
Jordi CarratalàService of Infectious Diseases, Bellvitge University Hospital, Bellvitge Biomedical Research Institute (IDIBELL), University of Barcelona, Hospitalet de Llobregat, Barcelona, Spain.
Sonia SantibáñezDepartment of Infectious Diseases, San Pedro-CIBIR University Hospital, Logroño, La Rioja, Spain.
Pedro Camacho-MartínezUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain.
Jerónimo PachónInstitute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain; Department of Medicine, University of Seville, Sevilla, Spain.
José Miguel CisnerosUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain.
Elisa CorderoUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain; Department of Medicine, University of Seville, Sevilla, Spain. Electronic address: elisacorderom@gmail.com.
Javier Sánchez-CéspedesUnit of Infectious Diseases, Microbiology, and Preventive Medicine, Virgen del Rocío University Hospital, Seville, Spain; Institute of Biomedicine of Seville (IBiS), Virgen del Rocío and Virgen Macarena /CSIC/University of Seville, Seville, Spain. Electronic address: jsanchezibis@us.es.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
COVID-19SARS-CoV-2Antibodies, ViralHumansNasopharynxViral LoadAntibodies, ViralCOVID-19Disease severityPrognosisRNAemiaSARS-CoV-2
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.